Webinar: Dr. Serge Verstovsek and the Latest Updates in MPN Treatment
- Peter Löffelhardt
- May 20
- 1 min read
We are excited to invite you to a new live webinar hosted by the Global MPN Scientific Foundation, featuring one of the world’s leading experts in Myeloproliferative Neoplasms (MPN), Dr. Serge Verstovsek.
🗓 Date: Thursday, May 29, 2025
🕕 Time: 6:00 PM – 7:00 PM (CEST)
📍 Online (Zoom)
Content guide
What’s this webinar about?
This exclusive session will provide the latest insights into the POIESIS clinical trial (by Karthos Therapeutics), a cutting-edge study focused on improving treatment for Myelofibrosis and other MPNs. Dr. Verstovsek will explain the science behind this innovative approach, why it matters, and what it could mean for patients worldwide.
About Dr. Serge Verstovsek
Dr. Verstovsek is a world-renowned physician-scientist. With over 100 clinical trials and 700+ publications, he is a reference in the field of MPN care and research.
What is POIESIS?
POIESIS is an international clinical trial exploring new mechanisms of action to treat MPNs, specifically Myelofibrosis. The study focuses on P53 activation to optimize response and improve quality of life for patients.
If you're a patient, caregiver, or professional interested in MPN research and innovation—this webinar is for you.
Spots are limited – make sure to register in time!
For questions, contact: events@gmpnsf.org
Comments